Overview
Abilify is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, the acute treatment of manic and mixed episodes associated with bipolar 1 disorder, and as an adjunctive…
Overview
Abilify Maintena is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and the maintenance monotherapy (single-drug treatment) of bipolar 1 disorder in adults. This…
Overview
Abilify Asimtufii is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and as a maintenance monotherapy (single-drug treatment) for bipolar 1 disorder in adults…